NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/15/2023
Back to search
Official data from USPTO
LYMPHASELECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LYMPHASELECT
ST13
US500000076215947Class
1, 5
Filing
76215947
Registration
2668084
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
07/15/2023
Trademark type
Word
Nice classes
1, 5
Filing date
02/26/2001
Registration date
12/31/2002
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/15/2023
Last transaction
07/15/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
1
Owner type
03
Owner location
Milan, IT
Examiner
HICKEY,TONI
Law office
M60
Current location
TMO LAW OFFICE 115
Holders and representatives
Holders
INDENA S.p.A.
INDENA S.p.A.
Representatives
ROBERT S. BRODER COLLARD & ROE, P.C.
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Natural chemicals having as active principle yellow melilot extract for use in the manufacture of cosmetics
Class 5
Pharmaceutical preparations having as active principle yellow melilot extract for use in treating chronic venous insufficiencyinflammationsphlebitis and thrombophlebitispost-traumatic lymphatic blockscellulitis
Publications
History of USPTO decisions and trademark events.
27 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
07/15/2023
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
07/15/2023
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
07/15/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/11/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
12/16/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
09/28/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/28/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/28/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/28/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
09/11/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/11/2008
PLGL
ASSIGNED TO PARALEGAL
09/04/2008
E815
TEAS SECTION 8 & 15 RECEIVED
08/27/2008
CFIT
CASE FILE IN TICRS
03/17/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2002
PUBO
PUBLISHED FOR OPPOSITION
10/08/2002
NPUB
NOTICE OF PUBLICATION
09/18/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/17/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/18/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/26/2002
PAPER RECEIVED
04/26/2002
CNSL
LETTER OF SUSPENSION MAILED
01/22/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/24/2001
1.BD
Sec. 1(B) CLAIM DELETED
09/24/2001
CNRT
NON-FINAL ACTION MAILED
07/10/2001
DOCK
ASSIGNED TO EXAMINER
06/25/2001
Continuous trademark protection
Get notified about every new filing that threatens LYMPHASELECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.